Cover Image


Product and Pipeline Analysis of the Global Parkinson's Disease Therapeutics Market

出版商 Frost & Sullivan 商品編碼 295018
出版日期 內容資訊 英文 52 Pages
商品交期: 最快1-2個工作天內
Back to Top
全球帕金森氏症治療市場上產品、開發平台分析 Product and Pipeline Analysis of the Global Parkinson's Disease Therapeutics Market
出版日期: 2014年02月04日 內容資訊: 英文 52 Pages




第1章 摘要整理

第2章 調查目的、範圍

第3章 簡介

  • 全球帕金森氏症得病率:各國
  • 全球帕金森氏症發病率:各國

第4章 市場概要

  • 市場概要:各治療類型的市場區隔
  • 市場概要:市場區隔說明
  • 市場機會概要

第5章 帕金森氏症治療藥市場

  • 競爭情形:上市藥、開發中的產品
  • 上市藥概要:帕金森氏症治療藥
  • 開發平台概要:帕金森氏症治療藥
  • 帕金森氏症治療藥市場:臨床實驗中的產品
  • 帕金森氏症治療藥市場:主要持續中臨床實驗的競爭情形
  • 以失敗作結的創新
  • 競爭情形:主要開發平台藥物的銷售計劃預測
  • 競爭情形:藥物開發平台各級的企業資產

第6章 產品儀表板

  • Stalevo (entacapone):Orion Corporation
  • Sinemet (carbidopa-levodopa):Merck
  • Azilect (rasagiline) : TEVA Pharmaceuticals
  • Mirapex (pramipexole) : Boehringer Ingelheim
  • Neupro (rotigotine) : UCB Pharmaceuticals
  • Requip (ropinrole) : GSK
  • Eldepryl (Selegiline hydrochloride) : Orion Corporation

第7章 結論、建議

第8章 附錄

第9章 關於Frost & Sullivan

Product Code: MA14-01-00-00-00

Rising Incidence of Disease Urges Strong Pipeline Development

This research service focuses on existing therapeutics and product pipeline for the treatment of Parkinson's Disease using Dopamine Replacement Therapies, Dopamine Agonists, MAO-inhibitors, COMT-inhibitors and other pharamcolgical approaches for current global interest. This research service does not cover vaccines. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for Parkinson's Disease therapeutics. Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology.

Table of Contents

1. Executive Summary

  • Mode of Drug Administration for Parkinson's Disease

2. Methodology and Scope

3. Introduction

  • Global Prevalence of Parkinson's Disease by Country
  • Global Incidence of Parkinson's Disease by Country

4. Market Overview

  • Market Overview-Segmentation by Types of Therapeutics
  • Market Overview-Segmentation Illustrated
  • Overview for Market Opportunities

5. Parkinson's Disease Therapeutics Market

  • Competitive Landscape-Marketed Products and Products in Development
  • Marketed Product Synopsis-Parkinson's Disease Therapeutics
  • Pipeline Synopsis-Parkinson's Disease Therapeutics
  • Parkinson's Disease Therapeutics Market-Products in Clinical Development
  • Parkinson's Disease Therapeutics Market-Competitive Landscape: Major Ongoing Trials
  • Innovations that Failed
  • Competitive Landscape-Projected Launch Timeline for Key Pipeline Drugs
  • Competitive Landscape-Company Assets by Drug Pipeline Class

6. Product Dashboards

  • Product Dashboard: Stalevo (entacapone)-Orion Corporation
  • Product Dashboard: Sinemet (carbidopa-levodopa)-Merck
  • Product Dashboard: Azilect (rasagiline) By TEVA Pharmaceuticals
  • Product Dashboard: Mirapex (pramipexole) By Boehringer Ingelheim
  • Product Dashboard: Neupro (rotigotine) By UCB Pharmaceuticals
  • Product Dashboard: Requip (ropinrole) By GSK
  • Product Dashboard: Eldepryl (Selegiline hydrochloride) By Orion Corporation

7. Conclusions and Recommendations

  • Key Companies to Watch
  • Legal Disclaimer

8. Appendix

9. The Frost & Sullivan Story

Back to Top